Contrast-enhanced digital mammography is an advanced modality of breast imaging, which helps in improvement of the breast cancer screening process. Contrast-enhanced digital mammography generates a contrast-enhanced, full-field, and high-resolution image of digital mammography, similar to MRI, to provide lesion vascularity details inside the breasts. The technology combines the standard, full-field digital mammography (FFDM) with a low-osmolarity, intravenous, iodinated contrast medium. Detecting malignancies in extremely dense and heterogeneous breasts with the help of MRI is difficult. Contrast-enhanced digital mammography highlights the malignant area with the help of a contrast agent, facilitating the tumor detection. In contrast-enhanced digital mammography, an iodine-based contrast medium is administered intravenously in the arm vein before capturing the mammographic image and two subsequent images at low energy and high energy are obtained. The low-energy image reveals calcification and soft tissue details. The two images are then subtracted to generate a single, contrast-enhanced digital image, which highlights the neovascularity inside the breasts. Owing to the fact that cancerous tissues take up more iodine than normal tissues, the resulting contrast-enhanced image maximizes the conspicuity of the contrast agent in the breasts. This reveals the lesions with higher neovascularity and approximately ten times the resolution of the normal breast MRI.
The superiority of contrast-enhanced digital mammography over the breast MRI and standard mammography in detecting breast tumors, rising prevalence of the breast cancer across the globe, and cost-effectiveness of the contrast-enhanced digital mammography modality are major factors estimated to fuel the contrast-enhanced digital mammography market during the forecast period. However, lack of awareness about the contrast-enhanced digital mammography technology among the people in developing countries is anticipated to restrain the market during the forecast period.
The global contrast-enhanced digital mammography market has been segmented based on image type and end-user. Based on image type, the market has been segmented into 2D images and 3D images. The 2D images segment dominated the market in 2016, due to rising awareness about the contrast-enhanced digital mammography procedure in developing countries. On the other hand, the 3D image segment is likely to register the maximum CAGR from 2017 to 2025. It is likely to lead the global market, in terms of revenue, during the forecast period. This estimated dominance of the segment is attributable to technically efficient and high-resolution screening of tumors and easy detection of the breast cancer with the help of 3D images.
Based on end-user, the global contrast-enhanced digital mammography market can be segmented into hospitals, diagnostic laboratories, clinics, and others. The hospitals segment accounted for the maximum market share in 2016, which is attributable to improved reimbursement policies for diagnostic imaging procedures and availability of well-equipped health care facilities in hospitals. The rising investment by public and private players in the health care sector is estimated to propel the hospitals segment of the global contrast-enhanced digital mammography market during the forecast period.
Geographically, the global contrast-enhanced digital mammography market has been segmented into five major regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the maximum market share in 2016, which is attributable to the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region and superiority of contrast-enhanced digital mammography over the standard MRI technique. On the other hand, Asia Pacific is likely to register the maximum CAGR from 2017 to 2025, owing to low cost of the contrast-enhanced digital mammography, shorter time required for the procedure as compared to standard MRI, and rapidly rising number of patients of breast cancer in the region. Increasing incidence of breast cancer in the U.S., and growing awareness of early detection and screening of breast cancer, are some of the major factors expected to drive the growth of the contrast-enhanced digital mammography market in North America during 2017-2025.
Prominent players operating in the global Contrast-enhanced Digital Mammography (CEDM) Market are Hologic, Inc., GE Healthcare, Planmed OY, and Allengers.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.